NCT04195295

Brief Summary

The prospective study is a interventional study to evaluate and compare the effectiveness of periosteal pedicle as grafting technique and egg shell derived nano hydroxyapatite as regenerative graft material for regeneration of intrabony defects.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 6, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 11, 2019

Completed
1 day until next milestone

Study Start

First participant enrolled

December 12, 2019

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2021

Completed
Last Updated

August 12, 2020

Status Verified

August 1, 2020

Enrollment Period

1.9 years

First QC Date

December 6, 2019

Last Update Submit

August 11, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Bone defect fill and density

    bone defect fill and bone density will be measured pre operatively and post operatively using CBCT

    6 months

Secondary Outcomes (1)

  • Probing pocket depth

    6 months

Study Arms (3)

periosteal membrane and egg shell graft

EXPERIMENTAL

Egg shell derived nano hydroxyapatite (EnHA) as regenerative graft material and periosteal pedicle as barrier membrane.

Procedure: Regeneration of Intrabony Defects with Nano Hydroxyapatite Graft, Derived from Egg Shell along with Periosteum as Barrier Membrane

only egg shell graft

EXPERIMENTAL

Only Egg shell derived nano hydroxyapatite (EnHA) as graft material.

Procedure: Regeneration of intrabony defects using Egg shell derived nano hydroxyapatite (EnHA) as regenerative graft material

open flap debridement

ACTIVE COMPARATOR

open flap debridement procedure only.

Procedure: Open flap debridement procedure in intrabony defects.

Interventions

* In group A, the full thickness mucoperiosteal flap will be elevated, which will be extended apically to expose sufficient amount of periosteum. * Periosteal membrane will be separated from the full thickness mucoperiosteal flap and released by one vertical incision mesially and one horizontal incision apically. * Posteriorly, the periosteum remained attached with the mucoperiosteal flap, so that blood supply could be maintained in the reflected periosteum. * Then the graft material will be packed into the defect. * Then periosteal membrane will be turned over the intrabony defect in such a way that the defect was completely covered by the periosteal membrane

periosteal membrane and egg shell graft

Full thickness mucoperiosteal flap will be raised and Vertical releasing incisions are used if necessary for better access to the surgical site. Then EnHA graft material will be placed into the defect before suturing the mucoperiosteal flap.

only egg shell graft

full thickness mucoperiosteal flap will be raised, entire granulation tissue will be removed from the defects, the pocket epithelium was curetted from the inner surface of the flap, and the roots were thoroughly scaled and planed by means of manual and ultrasonic instruments. Then the operative area will be irrigated with sterile saline. After that, the mucoperiosteal flaps will be sutured.

open flap debridement

Eligibility Criteria

Age25 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients within the age group of 25 to 55 years.
  • Patients with chronic periodontitis, with presence of intrabony defects with ≥6mm probing depth (PD), 2 or 3 wall defects as detected on CBCT.
  • Gingival biotype \>1.5mm
  • Systemically healthy subjects.
  • Patients who are compliant.
  • Patients who had not received any periodontal treatment in the last six months.

You may not qualify if:

  • Pregnant and Lactating females.
  • Aggressive periodontitis.
  • Presence of pulpal or periapical involvement.
  • Patients with known systemic diseases and conditions precluding any elective surgery.
  • Patients who were smokers.
  • Teeth with poor prognosis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Krishnadevaraya college of dental sciences

Bangalore, Karnataka, 562157, India

RECRUITING

Study Officials

  • Dr. Rashmi P, MDS

    Krishnadevaraya College of Dental Sciences

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Dr. Rashmi P, MDS

CONTACT

Dr. Sri Vani T. M, MDS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor and HOD

Study Record Dates

First Submitted

December 6, 2019

First Posted

December 11, 2019

Study Start

December 12, 2019

Primary Completion

November 1, 2021

Study Completion

November 1, 2021

Last Updated

August 12, 2020

Record last verified: 2020-08

Data Sharing

IPD Sharing
Will not share

Locations